Bausch Health Companies | VRX - Market Capitalization


Bausch Health Companies reported $2.88B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 195.44B 5.55B Jun/2026
ANI Pharmaceuticals USD 1.88B 133M Jun/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Bausch Health Companies USD 2.61B 200M Jun/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Canopy Growth CAD 557.13M 99.33M Mar/2026
Corcept Therapeutics USD 9.33B 5.02B Jun/2026
Danaher USD 138.86B 10.4B Jun/2026
Drreddys Laboratories INR 11.07B 619M Mar/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 998M 83M Jun/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.24B 566M Jun/2026
Supernus Pharmaceuticals USD 2.7B 277M Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026
Zoetis USD 30.13B 19.58B Jun/2026